Enterprise Bank & Trust CO Eli Lilly & CO Transaction History

Enterprise Bank & Trust CO

$291 Million
Q2 2024

A detailed history of Enterprise Bank & Trust CO transactions in Eli Lilly & CO stock. As of the latest transaction made, Enterprise Bank & Trust CO holds 6,958 shares of LLY stock, worth $6.28 Million. This represents 2.16% of its overall portfolio holdings.

Number of Shares

6,958

Previous 7,334 5.13%

Holding current value

$6.28 Million

Previous $5.71 Million 10.41%

% of portfolio

2.16%

Previous 1.97%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 10, 2024	SELL	$724.87 - $909.04 $272,551 - $341,799	-376 Reduced 5.13%	6,958 $6.3 Million
Q1 2024 Apr 10, 2024	SELL	$592.2 - $792.28 $580,356 - $776,434	-980 Reduced 11.79%	7,334 $5.71 Million
Q4 2023 Jan 09, 2024	SELL	$525.19 - $619.13 $392,316 - $462,490	-747 Reduced 8.24%	8,314 $4.85 Million
Q3 2023 Oct 16, 2023	SELL	$434.7 - $599.3 $129,975 - $179,190	-299 Reduced 3.19%	9,061 $4.87 Million
Q2 2023 Jul 06, 2023	SELL	$350.74 - $468.98 $102,766 - $137,411	-293 Reduced 3.04%	9,360 $4.39 Million
Q1 2023 Apr 11, 2023	SELL	$310.63 - $364.82 $141,026 - $165,628	-454 Reduced 4.49%	9,653 $3.32 Million
Q4 2022 Jan 11, 2023	SELL	$321.55 - $374.67 $15,434 - $17,984	-48 Reduced 0.47%	10,107 $0
Q3 2022 Oct 06, 2022	SELL	$296.48 - $337.87 $85,979 - $97,982	-290 Reduced 2.78%	10,155 $3.28 Million
Q2 2022 Jul 06, 2022	SELL	$278.73 - $327.27 $413,914 - $485,995	-1,485 Reduced 12.45%	10,445 $3.39 Million
Q1 2022 Apr 13, 2022	SELL	$234.69 - $291.66 $173,201 - $215,245	-738 Reduced 5.83%	11,930 $3.42 Million
Q4 2021 Jan 03, 2022	SELL	$224.85 - $279.04 $6,070 - $7,534	-27 Reduced 0.21%	12,668 $3.5 Million
Q3 2021 Oct 04, 2021	SELL	$221.6 - $272.71 $58,502 - $71,995	-264 Reduced 2.04%	12,695 $2.93 Million
Q2 2021 Jul 06, 2021	SELL	$180.55 - $233.54 $180 - $233	-1 Reduced 0.01%	12,959 $2.97 Million
Q1 2021 Apr 15, 2021	SELL	$164.32 - $212.72 $5,258 - $6,807	-32 Reduced 0.25%	12,960 $2.42 Million
Q4 2020 Jan 05, 2021	BUY	$130.46 - $172.63 $131,373 - $173,838	1,007 Added 8.4%	12,992 $2.19 Million
Q3 2020 Oct 16, 2020	SELL	$146.22 - $169.13 $31,729 - $36,701	-217 Reduced 1.78%	11,985 $1.77 Million
Q2 2020 Jul 10, 2020	BUY	$136.42 - $164.18 $273,385 - $329,016	2,004 Added 19.65%	12,202 $2 Million
Q1 2020 Apr 07, 2020	SELL	$119.05 - $147.35 $42,619 - $52,751	-358 Reduced 3.39%	10,198 $1.42 Million
Q4 2019 Jan 07, 2020	BUY	$106.92 - $132.43 $29,082 - $36,020	272 Added 2.64%	10,556 $1.39 Million
Q3 2019 Oct 07, 2019	BUY	$106.79 - $116.16 $839,049 - $912,669	7,857 Added 323.73%	10,284 $1.15 Million
Q2 2019 Jul 12, 2019	BUY	$110.79 - $129.32 $19,942 - $23,277	180 Added 8.01%	2,427 $269,000
Q1 2019 Apr 24, 2019	BUY	$111.31 - $131.02 $250,113 - $294,401	2,247 New	2,247 $292,000

Others Institutions Holding LLY

# of Institutions

3,865

Shares Held

751M

Call Options Held

6.34M

Put Options Held

7.97M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $858B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Enterprise Bank & Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Enterprise Bank & Trust CO with notifications on news.

Account

Enterprise Bank & Trust CO Eli Lilly & CO Transaction History